Folate-Boosted Oral Contraceptive is intended to reduce the risk for rare neural tube defects in a pregnancy conceived during its use or shortly thereafter The US Food and Drug Administration (FDA) has approved an oral contraceptive Safyral in which 451 μg levomefolate calcium has been added to each tablet of a 21/7 drospirenone 3 mg/estradiol […]